Metraipolis › archive › dc_504379e1dafe

Clinical characteristics, cerebellar MR spectroscopy and response to 3,4-diaminopyridine in spinocerebellar ataxia 27B: the Sheffield Ataxia Centre experience — Europe PMC PMID:41065930

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41065930
DOI
10.1007/s00415-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-09T10:42:16.669Z
SHA-256 of the archived text
d53a29f302fb44974a3ecc99724422c96eba221bdeb949ce3b501c9a3c32cb73
Stable URL of this page
https://metraipolis.com/documento/dc_504379e1dafe

How to cite

Clinical characteristics, cerebellar MR spectroscopy and response to 3,4-diaminopyridine in spinocerebellar ataxia 27B: the Sheffield Ataxia Centre experience — Europe PMC PMID:41065930 — Europe PMC (en), https://europepmc.org/article/MED/41065930 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_504379e1dafe (Metraipolis archive dc_504379e1dafe, sha256 d53a29f302fb44974a3ecc99724422c96eba221bdeb949ce3b501c9a3c32cb73)
BibTeX
@misc{dc504379e1dafe,
  title = {Clinical characteristics, cerebellar MR spectroscopy and response to 3,4-diaminopyridine in spinocerebellar ataxia 27B: the Sheffield Ataxia Centre experience — Europe PMC PMID:41065930},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41065930},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_504379e1dafe; sha256 d53a29f302fb44974a3ecc99724422c96eba221bdeb949ce3b501c9a3c32cb73},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41065930. Agents can read the archived copy with the MCP tool read_document.